Company Quick10K Filing
Propanc Biopharma
S-1 2020-05-13 Public Filing
10-Q 2020-03-31 Filed 2020-05-15
10-Q 2019-12-31 Filed 2020-02-14
S-1 2019-12-12 Public Filing
10-Q 2019-09-30 Filed 2019-11-14
10-K 2019-06-30 Filed 2019-10-15
S-1 2019-05-23 Public Filing
10-Q 2019-03-31 Filed 2019-05-15
S-1 2019-02-25 Public Filing
10-Q 2018-12-31 Filed 2019-02-14
S-1 2018-10-17 Public Filing
10-Q 2018-09-30 Filed 2018-11-13
10-K 2018-06-30 Filed 2018-09-17
10-Q 2018-03-31 Filed 2018-05-10
10-Q 2017-12-31 Filed 2018-02-09
10-Q 2017-09-30 Filed 2017-11-09
10-K 2017-06-30 Filed 2017-09-28
10-Q 2017-03-31 Filed 2017-05-08
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-10
10-K 2016-06-30 Filed 2016-09-28
10-Q 2016-03-31 Filed 2016-05-16
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-16
10-K 2015-06-30 Filed 2015-09-30
10-Q 2015-03-31 Filed 2015-05-15
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-19
10-K 2014-06-30 Filed 2014-10-14
10-Q 2014-03-31 Filed 2014-05-20
10-Q 2013-12-31 Filed 2014-02-14
10-K 2013-06-30 Filed 2013-10-15
10-Q 2013-03-31 Filed 2013-05-20
10-Q 2012-12-31 Filed 2013-02-20
10-K 2012-10-11 Filed 2012-10-15
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-03-31 Filed 2012-05-21
10-Q 2011-12-31 Filed 2012-02-21
8-K 2020-03-30
8-K 2020-01-13
8-K 2019-10-02
8-K 2019-09-03
8-K 2019-07-31
8-K 2019-07-03
8-K 2019-06-24
8-K 2019-06-21
8-K 2019-05-23
8-K 2019-05-14
8-K 2019-02-25
8-K 2019-02-12
8-K 2018-12-24
8-K 2018-11-30
8-K 2018-10-05
8-K 2018-10-02
8-K 2018-09-21
8-K 2018-09-07
8-K 2018-08-28
8-K 2018-07-13
8-K 2018-06-29
8-K 2018-06-26
8-K 2018-06-14
8-K 2018-04-13
8-K 2018-04-10
8-K 2018-03-23
8-K 2018-03-16
8-K 2018-03-14
8-K 2018-02-20
8-K 2018-01-22
8-K 2017-12-29

Propanc Biopharma Financials

PPCB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Yulong Eco-Materials (YECO) 1,133 31% 0.0 -200% 33,278 29,559 10,084 3,137 -66,490 -64,932 -681
MicroChannel Technologies (MCTC) 29,418 -997.6 0 158 0 0 -29 -29 29,418
Capstone Therapeutics (CAPS) 1,088 -1.4 -315% 703 3,463 0 0 -2,216 -2,173 2,961
Franchise Holdings International (FNHI) 1,086 20% -9.2 -19% 848 1,267 1,448 293 -158 -103 950
Oncolix (ONCX) 1,085 -1.0 -2,427% 297 7,602 0 0 -7,200 -6,988 7,169
Q2Earth (QPWR) 1,040 0% 6.5 1,037% 15 4,036 3,142 0 159 159 1,037
ColorStars (CSTU) 1,023 100% -8.6 -119% 101 450 7 7 -121 -119 1,015
Arias Intel (ASNT) 1,014 -0.1 -1,260% 723 6,449 0 0 -9,111 -8,536 1,014
Altex Industries (ALTX) 984 0% -183.1 -1% 2,344 1,091 56 0 -32 7 -1,282
Propanc Biopharma (PPCB) 983 -1.0 -2,593% 198 4,739 0 -24 -5,125 -3,561 3,434
TX Holdings (TXHG) 961 16% 8.3 2% 2,141 4,095 3,935 621 42 174 1,438
Axion Power (AXPW) 960 -2,624% -0.1 -1,826% 578 8,143 58 -1,527 -10,558 -10,312 759
GeoVax Labs (GOVX) 956 0% -0.2 -218% 817 1,837 907 0 -1,780 -1,771 416
Virtual Crypto Technologies (VRCP) 922 98% -1.2 -271% 235 1,546 63 62 -638 -642 756
ZIM (ZIMCF) 895 -0% 0 0 0 0 388
Blue Sphere (BLSP) 894 34% -0.6 -33% 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Network CN (NWCN) 877 -24.4 -625% 108 12,530 0 0 -673 -240 5,872
United States Basketball League (USBL) 843 -13.8 -181,665% 0 2,375 0 0 -62 -61 843
Eco-Mat (ECMT) 842 -12.1 0 226 0 0 -81 -70 842
Towerstream (TWER) 828 0% -14.7 -40% 18,419 42,859 18,768 0 -7,325 -2,409 35,354

Balance Sheet ($'000)2012-03-312012-09-302012-10-112012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3910000371088515168108771,1681,479121254396914311292039125107296
Accounts Receivable
Inventory
PP&E541644150001511644425121111261010925899277
Assets2,159274612423912011452533106273051,5081,62337918113645951631291117183713260102198
Accounts Payable3823919219821127325931133235049882912363031071593703264424524846071,4391,2101,1571,1341,063855917960
Long-Term Debt7824,3504,3504,3501002,6513,4804,6534,4174,5154,6993,7592,7902,0681,6572,547
Liabilities4826375846567527941,2571,0621,1651,5221,8361,9302,1613,6813,4874,8645,1442,9441,9853,9764,7605,5376,9007,2786,8846,8235,6414,6173,6734,4034,739
Stockholders' Equity1,676-610-538-643-748-792-1,218-1,050-1,165-1,408-1,784-1,877-1,851-3,054-3,182-3,356-3,521-2,565-1,804-3,841-4,715-5,442-6,738-7,149-6,773-6,752-5,558-3,904-3,413-4,301-4,542
Income Statement ($'000)2012-03-312012-09-302012-10-112012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000
Cost of Revenue867611
Gross Profit-8-6-7-11
R&D00-0201100084291191531435106401611673862575641,212751525695535765
SG&A3,0904932,5424422261763063031021122312445055878499967752,8061,0051,9651,153846631405724353385657512773833
Tax000001000-00-82320-720-1000000-000-117110
Net Income-3,096-493-2,5592,216-338-225-57226-67-218-783-345-454-1,827-839-3,562-2,152-2,857-1,102-3,761-1,371-1,633-1,924-2,202-1,491-1,422-2,125-1,450-582-1,602-1,492
Cash Flow ($'000)2012-03-312012-09-302012-10-112012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-72-56-6-19-32-75-27-36364100172-426-729-627-861-717-2,294-684-321-444-602-786-286-659-419-737-266-726
Cash Investing0000000000-1-5-1000000-10
Cash Financing7517-12529113-224616835865984152,0531,200867614345429711894380619480694198865